Literature DB >> 24691946

[Update on the pharmacology and effects of local anesthetics].

J Ahrens1, A Leffler.   

Abstract

Local anesthetics (LA) are broadly used in all disciplines and it could be considered that relatively little is reflected on the mechanisms of action of this old substance group. However, several molecular mechanisms of LAs mediating wanted and unwanted effects remain to be explored. Furthermore, the number of indications for application of LAs seems to be expanding. The local anesthetic effect of LAs is primarily mediated by a potent inhibition of voltage-gated sodium channels. However, this effect is due to much more than the interaction of LAs with one single molecule. Most recent studies indicated that the development of selective local anesthetics might be possible and LAs also interact with several other membrane molecules. Although the relevance of these effects is still unclear, they might play a role in systemic analgesia, tissue protection and anti-inflammatory effects of LA. The therapeutic index of systemically applied LA is very narrow. Systemic application is formally not permitted because the impending systemic toxicity is still a life-threatening complication. Although the cardiac and central nervous toxicity at least partly result from an unselective block of neuronal and cardiac sodium channels, preclinical studies suggest the involvement of several mechanisms. A local LA toxicity is less clinically impressive; however, all LAs induce a significant tissue toxicity for which the underlying mechanisms have been partly identified. This review reports on recent findings on mechanisms and on the clinical relevance of some LA-induced effects which are of relevance for anesthesiological activities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24691946     DOI: 10.1007/s00101-014-2302-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  97 in total

1.  Association between epidural analgesia and cancer recurrence after colorectal cancer surgery.

Authors:  Antje Gottschalk; Justin G Ford; Cedric C Regelin; Jing You; Edward J Mascha; Daniel I Sessler; Marcel E Durieux; Edward C Nemergut
Journal:  Anesthesiology       Date:  2010-07       Impact factor: 7.892

2.  Adverse outcomes associated with stimulator-based peripheral nerve blocks with versus without ultrasound visualization.

Authors:  Steven L Orebaugh; Brian A Williams; Manuel Vallejo; Michael L Kentor
Journal:  Reg Anesth Pain Med       Date:  2009 May-Jun       Impact factor: 6.288

3.  The effects of lidocaine on inhibition in the cerebral cortex.

Authors:  J E Warnick; R D Kee; G K Yim
Journal:  Anesthesiology       Date:  1971-04       Impact factor: 7.892

4.  Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial μ-opioid receptor agonist buprenorphine.

Authors:  Andreas Leffler; Georg Frank; Katrin Kistner; Florian Niedermirtl; Wolfgang Koppert; Peter W Reeh; Carla Nau
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

5.  Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro.

Authors:  P Lirk; R Berger; M W Hollmann; H Fiegl
Journal:  Br J Anaesth       Date:  2012-04-27       Impact factor: 9.166

6.  The effectiveness of local anesthetics in preventing postoperative adhesions in rat models.

Authors:  E Ozturk; A Yilmazlar; S Berhuni; T Yilmazlar
Journal:  Tech Coloproctol       Date:  2010-10-08       Impact factor: 3.781

Review 7.  Models and mechanisms of local anesthetic cardiac toxicity: a review.

Authors:  John F Butterworth
Journal:  Reg Anesth Pain Med       Date:  2010 Mar-Apr       Impact factor: 6.288

Review 8.  Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials.

Authors:  Grace C McCarthy; Sohair A Megalla; Ashraf S Habib
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

Review 9.  The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

Authors:  Michael A Rogawski; Wolfgang Löscher
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

10.  ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors.

Authors:  William A Schmalhofer; Jeffrey Calhoun; Rachel Burrows; Timothy Bailey; Martin G Kohler; Adam B Weinglass; Gregory J Kaczorowski; Maria L Garcia; Martin Koltzenburg; Birgit T Priest
Journal:  Mol Pharmacol       Date:  2008-08-26       Impact factor: 4.436

View more
  2 in total

Review 1.  [Liposomal bupivacaine-No breakthrough in postoperative pain management].

Authors:  Berit Otremba; Hanns-Christian Dinges; Ann-Kristin Schubert; Wolfgang Zink; Thorsten Steinfeldt; Hinnerk Wulf; Thomas Wiesmann
Journal:  Anaesthesiologie       Date:  2022-04-25

2.  Effects of Using Tricaine Methanesulfonate and Metomidate before Euthanasia on the Contractile Properties of Rainbow Trout (Oncorhynchus mykiss) Myocardium.

Authors:  Jordan C Roberts; Douglas A Syme
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.